Results 211 to 220 of about 672,953 (296)

Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment. [PDF]

Am J Respir Crit Care Med
Ding Y, Zhang Y, Su X, Wu Y, Zhang N, Wu K.   +5 more
europepmc   +1 more source

B cells and systemic sclerosis interstitial lung disease

Arthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman, Voon Ong, Christopher Denton   +2 more
wiley   +1 more source

Long-Term Effectiveness of BAY e 5009-Nitrendipine in the Treatment of Mild and Moderate Arterial Hypertension

, 1984
Ricardo J. Esper, Roberto C. Esper, H Baglivo, Jos M. Castro, R. Rohwedder, A Menna   +5 more
openalex   +1 more source

Essential arterial hypertension and stone disease [PDF]

, 1999
Loris Borghi, Tiziana Meschi, Angela Guerra, Angelo Briganti, Tania Schianchi, Franca Allegri, A Novarini   +6 more
openalex   +1 more source

DNA Damage in Pulmonary Arterial Hypertension and Veno-Occlusive Disease-FANCL as Dual Rescue? [PDF]

Am J Respir Crit Care Med
Pak O, Weissmann N, Sommer N.
europepmc   +1 more source

Impact of diclofenac risk minimization measures addressing cardiovascular risk on analgesic use in musculoskeletal disorders

British Journal of Clinical Pharmacology, EarlyView.
Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys, Yared Santa‐Ana‐Tellez, Satu J. Siiskonen, Daniala L. Weir, Rolf H. H. Groenwold, Helga Gardarsdottir   +5 more
wiley   +1 more source

Symposium on Arterial Hypertension, Deauville

, 1980
J Cardiouasc Pharmacol
openalex   +1 more source

The Myogenic Response of Arterial Vessels Is Increased in Fetal Pulmonary Hypertension [PDF]

, 1995
Jaques Belik
openalex   +1 more source

Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to identify distinct trajectories of lipid‐modifying medication (LMM) persistence over time and to explore characteristics associated with each pattern. Methods Using primary care data from IQVIA, we conducted a retrospective cohort study of adults prescribed LMMs between January 2015 and December 2017, with 5 years of follow‐up ...
Zhomart Orman, Jia Wei Koh, Caroline Trin, Zanfina Ademi, Ella Zomer, Danielle Berkovic, Jenni Ilomaki, J. Simon Bell, Danny Liew, Christopher M. Reid, Sean Lybrand, Brittany Schoeninger, Stella Talic   +12 more
wiley   +1 more source

Thyroid dysfunction and pulmonary arterial hypertension: A bidirectional mendelian randomization study. [PDF]

Int J Cardiol Heart Vasc
Pang G, Wang X, Zhao R, Yang P, Chen J, Guo Y, Liang C.   +6 more
europepmc   +1 more source